Product Description |
Recombinant Human Kallikrein 5/KLK5 Protein is expressed from HEK293 with His tag and Flag tag at the C-terminus.It contains Ile67-Ser293. |
Product Background |
The inhibition of kallikrein 5 (KLK5) has been identified as a potential strategy for treatment of the genetic skin disorder Netherton syndrome, in which loss-of-function mutations in the SPINK5 gene lead to down-regulation of the endogenous inhibitor LEKTI-1 and profound skin-barrier defects with severe allergic manifestations. To aid in the development of a medicine for this target, an X-ray crystallographic system was developed to facilitate fragment-guided chemistry and knowledge-based drug-discovery approaches. |
Product Category |
Recombinant Protein / Antibody discovery / Antibody discovery | Others |
Protein |
Kallikrein 5/KLK5 |
Synonyms |
Kallikrein c; Klnc; KLK5; KLKL2; KLK-L2; SCTE |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Ile67-Ser293 |
Molecular Weight |
The protein has a predicted MW of 31.7 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
Product Tag |
C-His-Flag |
Expression System |
HEK293 |
Purity |
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC |
Endotoxin |
Less than 1 EU per ug by the LAL method. |
Form |
Liquid |
Shipping |
Shipped with dry ice. |
Formulation |
Supplied as 0.22 um filtered solution in 50mM MES, 150mM NaCl (pH 5.5). |
Stability And Storage |
Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Related Products
Have more questions?
Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.
Contact Us
More from Antibody Drug Discovery Proteins
Recently viewed